CANLI
Yükleniyor Veriler getiriliyor…
/ Atıflar / Detay

Atıf Detayı

Kurum makalesi · Scopus üzerinden alınan atıf kaydı

Kurumun Atıf Alan Makalesi
Atıf Alan Yayın
Screening of in vitro antioxidant and enzyme inhibitory activities of different extracts from two uninvestigated wild plants: Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata
European Journal of Integrative Medicine Cilt 8 ss. 286-292
Scopus Toplam 130 atıf DOI
Introduction The importance of plants products in traditional medicine has been recognized for some time. Two plants of Turkish origin, Centranthus longiflorus subsp. longiflorus and Cerinthe minor subsp. auriculata used as traditional Turkish medicine have remained uninvestigated for Alzheimer diseases and diabetes mellitus for their in vitro biological activity despite their use for sleep disorders. The antioxidant and enzyme inhibitory properties of these plants have not been reported. The aim of this study was to determine the total phenolics, flavonoids, and antioxidant as well as their enzyme inhibitory activity (in aqueous and solvent extracts). Methods Antioxidant assays used standard methods to assess phosphomolybdenum, free radical scavenging activity, reducing power, and metal chelating activity on ferrous ions. Additionally, the extracts were tested also for enzyme inhibitory activity (Cholinesterase, Tyrosinase, α-amylase, and α-glucosidase). Results Organic extracts showed the highest anti-cholinesterase (AChE, and BChE) activity, while aqueous extracts showed valuable Tyrosinase inhibitory activity. Total phenolics (expressed as gallic acid equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 46.2 and 25.4 mg in methanolic extracts, 27.5 and 26.2 mg in ethyl acetate extracts, and 37.9 and 46.6 mg in aqueous extracts, respectively. Similarly, total flavonoids (expressed as rutin equivalents) in C. longiflorus subsp. longiflorus and C. minor subsp. auriculata were 39.9 and 27.8 mg in methanolic extracts, 17.6 and 52.4 mg in ethyl acetate extracts, and 24.35 and 24.6 mg in aqueous extracts, respectively. Conclusion The reported results may be valuable for preparing new food supplements and can represent a good model for the development of new drug formulations.
Atıf Kaynağı
Atıf Yapan Yayın
Phenolic profile and pharmacological propensities of Gynandriris sisyrinchium through in vitro and in silico perspectives
Industrial Crops and Products Cilt 121 ss. 328-337
Scopus Havuzumuzda 13 atıf almış
Gynandriris sisyrinchium is a traditionally used medicinal plant, yet there is a dearth of scientific information on its biological potential and polyphenolic profile. In this endeavour, we aimed to assess and compare the biological properties of different extracts (ethyl acetate, methanol, and water) of G. sisyrinchium based on enzyme inhibitory effects coupled with docking studies and antioxidant ability together with screening of bioactive compounds. Polyphenolic composition was assessed by determining total phenolic (TPC) and flavonoid (TFC) content as well as individual phenolic compounds by RP-HPLC-DAD. The antioxidant properties were determined by different assays including free radical scavenging (ABTS and DPPH), reducing power (CUPRAC and FRAP), phosphomolybdenum, and metal chelating. The enzyme inhibitory activities of the extracts were evaluated for the first time against cholinesterases, tyrosinase, α-amylase, and α-glucosidase. Docking studies were performed to elucidate the interactions of phenolic compounds with the enzymes. Results show that the methanol extract exerted better scavenging, reducing, tyrosinase, and α-glucosidase inhibitory activities while the less polar ethyl acetate extract showed better phosphomolybdenum and metal chelating activity, AChE, BChE, and α-amylase inhibition. The most abundant compounds were apigenin (4224 and 1876 μg/g extract in the methanolic and ethyl acetate extract, respectively), benzoic acid (1870 μg/g extract in the methanolic extract), p-coumaric acid (472 μg/g extract in the methanolic extract), and quercetin (348 μg/g extract in the methanolic extract). The present findings suggest that G. sisyrinchium can be considered as a potential source of bioactive compounds for novel phytopharmaceuticals development in the treatment and/or management of noncommunicable diseases.
Atıf Yapan Makale Bilgileri
Kurumlar (4)
REEF Environmental Consultancy Puducherry, India
Selçuk Üniversitesi Selçuklu, Turkey
University of G. d'Annunzio Chieti and Pescara Chieti, Italy
University of Mauritius Reduit, Mauritius